Nicole Kirchhammer

5PUBLICATIONS
58CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 05, 2026
Cytotoxic CD39+ tumor-associated NK cells respond to NKG2A blockade in lung cancer.

|Feb 02, 2023
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.

Marcel P Trefny, Nicole Kirchhammer, Priska Auf der Maur

|Nov 09, 2022
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment.

Nicole Kirchhammer, Marcel P Trefny, Priska Auf der Maur

|Nov 02, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade.

Michal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer

|Jul 20, 2022
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity.

Nicole Kirchhammer, Marcel P Trefny, Marina Natoli

Pageof 1

Frequent Collaborators

5 joint publications

Marcel P Trefny

5 joint publications

Alfred Zippelius

4 joint publications

Heinz Läubli

2 joint publications

Marina Natoli